
Cipla CEO- Not letting Tariffs on Indian drugmakers
President, Donald Trump: The U.S. government has been considering tariff hikes on imports from various sectors, including pharmaceuticals, as part of broader trade policy measures. India’s basic customs duty on pharmaceutical imports is 10%. However, some lifesaving drugs and vaccines are exempt from this duty. Recently, the Indian